Northrop Grumman Corporation (NOC)

Investment Committee Summary

Investment Thesis

At $549, roughly 20 times forward earnings, the tape prices Northrop as a steady mid-cycle defence compounder: backlog converting at a reliable clip, a segment margin near 10% holding, and capital returned through repurchase and dividend. The engine agrees on the direction of the business and disagrees on the reward. Applying the same base multiple to base earnings barely reproduces the current price, while the simulation median and the capital-expenditure-bridge cash-flow anchor both land well beneath the market; only the peer-multiple read flatters it. The probability-weighted value is $496 and triangulation settles at $428, a gap of -22% to the current price, so the shares are trading rich to that anchor, which is what drives the SELL. This is not a call that rearmament ends. It is a statement that a rising capital schedule and net debt of ~$15.0B leave no margin of safety once meaningful structural and cyclical weights are respected. The single most damaging risk is program execution: a large adverse estimate-at-completion revision on fixed-price development work would cut the earnings base and the multiple at once, which is exactly the mechanism the trough scenario models.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($549) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The strongest bear case is not the structural tail but the mid-cycle base failing to deliver. It assumes backlog conversion and margin both hold; both are execution outcomes rather than entitlements. Northrop carries fixed-price development exposure where a single adverse estimate-at-completion revision can erase a year of margin progress, and management's own tone last quarter read as caution rather than confidence. If book-to-bill slips below parity for consecutive prints while the capital schedule keeps rising and dilutes returns, base earnings erode toward the cyclical path without any budget decision going against the company. A market paying a full multiple for stability inherits that downside first, because the premium sits entirely in the multiple rather than in the cash flows. In the structural leg — a genuine defence retrenchment layered on top of program losses — earnings and the multiple compress together and the target sits below the 52-week low.

Key Debate

Gross Margin explains 64% of Monte Carlo outcome variance — the single variable that decides which side is right.

What the Market Is Pricing In

At the current price, the market pays 18.9× consensus forward EPS, vs the house DCF terminal 15.0×, and a peer median 38.3×. The house DCF sits 32% below spot, so the market is pricing in more than the house case — roughly 2.8pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Defense-Budget Cuts / Aero-Production Halt' downside ($236) to a 'Bull — Re-Rate' bull case ($869); the probability-weighted blend (PWEV $496) is -10% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.3% of revenue; free cash flow net of SBC is $3.19B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

• Structural — Defense-Budget Cuts / Aero-Production Halt (20%, $236). Structural impairment — defense-budget cuts / aero-production halt: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Cyclical Downturn — Air-Traffic / Program Recession (17%, $358). Cyclical downturn — defense budgets + commercial-aero OE/aftermarket cycle + program execution weakens for 1–2 years before normalising.
• Base — Backlog + Aftermarket (35%, $521). Mid-cycle — normalised defense budgets + commercial-aero OE/aftermarket cycle + program execution; disciplined capital allocation; steady returns.
• Growth — Rearmament / Air-Traffic Recovery (20%, $678). Upside — rearmament + air-traffic recovery lifts earnings above mid-cycle; the multiple expands modestly.
• Bull — Re-Rate (8%, $869). Upside tail — sustained tight conditions or a structural re-rate on rearmament + air-traffic recovery.

Valuation Triangulation

Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $440 and 36% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (64% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.5%, 15.0x terminal FCF multiple → $375. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $1,574; the peer-median forward P/E is 38.3x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 242% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Aerospace & Defense multiple (AI re-rating) (base 18.0x)

Peer Quality & Weighting

Quality-weighted forward P/E: 27.8× (simple median 38.3×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $482–$771, centre $609 (+11% vs spot); spot sits at the 23rd percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Re-Rate): $869.

Company Overview & Business Model

Northrop Grumman Corporation — INDUSTRIALS · AEROSPACE & DEFENSE. Northrop Grumman Corporation (NYSE: NOC) is an American multinational aerospace and defense technology company.

How it makes money.

Edge. Wide moat. Authored moat rationale withheld pending re-authoring.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 114% — cash-backed.

Competitive Moat

Moat sources:

• Sole-source / classified prime positions (B-21 bomber, Sentinel ICBM, space & missile systems)
• Multi-year funded backlog providing revenue visibility and switching-cost lock-in for the government customer
• Prohibitive barriers to entry: security clearances, specialized facilities, and decades of program-execution IP
• Consolidated prime-contractor structure limiting competitive bidders on major programs

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.44 vs analyst floor +0.01 → delta +0.42 (n=24 mgmt / 21 Q&A; 54th pctile across the S&P book, z +0.1).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 1563 articles): avg ticker sentiment +0.20 (bullish 16% / bearish 2%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-09-15 (~22d) — B-21 production-lot ramp decision (authored)
• 2026-10-20 (~57d) — Quarterly earnings — est. EPS $7.14 (AV EARNINGS_CALENDAR)
• 2026-12-01 (~99d) — FY27 defense appropriations / NDAA outcome for Sentinel & B-21 (authored)
• 2027-01-15 (~144d) — Sentinel ICBM re-baseline milestone (authored)

Forecast Track Record

• EPS surprise: beat 88% of the last 8 quarters; average surprise +3.1%.
• Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 25%; mean predicted -7.3% vs realised +1.1%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

7 catalysts in the next 90 days (of 17 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Book-to-bill (total company, trailing four quarters) < 1.0 (2 consecutive prints). Sustained book-to-bill below parity signals the backlog is draining faster than it is being replaced, undercutting the mid-cycle volume path that carries the Base scenario.
• Segment operating margin < 0.102 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Revenue growth (year over year) < 0.03 (2 consecutive prints). Growth below the midpoint of the base (0.07) and cyclical (-0.01) drivers marks the transition from mid-cycle backlog conversion toward the cyclical-recession path.
• Free cash flow conversion (FCF / net income) < 0.8 (2 consecutive prints). Weak conversion alongside a rising capex schedule would confirm the DCF fear that new spend is value-dilutive rather than accretive, pressuring the buyback and dividend cadence.
• Enacted US defense procurement + RDT&E outlay growth < 0.0 (single event). A nominal cut to enacted procurement/RDT&E budgets is the discrete trigger for the structural-impairment path; it removes the demand floor the whole thesis rests on.
• Net EAC (estimate-at-completion) charge on fixed-price programs, annual > 0.5 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $549; 52-week range $482–$771; engine rating SELL; house target $504 (-8%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
• INFERENCE: Triangulated FV $428 (-22% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

57.8/100 (confidence band 46.2–69.4), 49th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 57.7 → 57.7 → 58.3 → 57.0 → 57.0 → 58.4 → 57.9 → 57.9.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $495.72.

Factor Exposures

Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.04, vs QQQ -0.06 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Protective Put. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• bearish/holder — hedge the position; a collar finances the put by capping upside
• Direction bearish from the overlay conviction/rating (read-only input).
• IV/RV at the 50th percentile of the cross-section → mid vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• Reported alongside and not used to select: this name's own ATM IV sits at the 67th percentile of its own month-end history (decile 7). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
• IV term structure is in contango (longer-dated richer, slope +4.8pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
• No live-chain Protective Put was priced for this name — shown as the indicated strategy; size against a freshly pulled chain.

IV term structure (contango, slope +4.8pp): 25-DTE 27% · 88-DTE 29% · 389-DTE 32%

No live-chain Protective Put was priced for this name — shown as the indicated approach; size against a fresh chain.

Alternatives: Collar, Put Debit Spread. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

research rating is SELL-tier — the model carries no long position.

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the SELL equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 26.9% (moderate regime) · expected move ±5.3% (2026-09-18) · put/call OI 1.17 · ATM Δ 0.52 / Θ -0.30 / ν 0.57 · next earnings 2026-10-20. Direction: NEUTRAL (implied return -22.0% to triangulated fair value $428.44).

Covered Call (if held) (Income / neutral) — Short 590 C · 2026-09-18 · premium $2.3 · yield 0.4% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.

Put Spread (income) (Income / would-own) — Short 505 P / Long 470 P · 2026-10-16 · net $6.39 · net entry $498.61 · yield 1.3% · RoR 22.0% · max loss $28.61 · priced from the listed chain (EOD marks)

Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.

Protective Collar (if held) (Hedge) — Long 495 P / Short 605 C · 2027-02-19 · net $6.35 · floor -10.0% · cap +10.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = SELL because:

• Probability-weighted scenario value implies -10% vs spot
• Monte Carlo median implies -20% vs spot
• DCF fair value implies -32% vs spot
• Bear case (Structural — Defense-Budget Cuts / Aero-Production Halt) downside is -57% vs spot
• Net: the valuation anchor itself sits 22.0% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating warrants a Sell.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.5% · Σ PV(FCF) $18B + PV(terminal) $51B = EV $69B; − net debt $15.0B → equity $54B ÷ diluted shares $0.14B = $375/share (exit-multiple terminal).

• Gordon terminal at 2.5% → $424/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 13% vs WACC 8.5% → above WACC — the build is value-creative.

Peer set

Implied prices at the peer medians: EV/Rev → $1,574 (no P/E-implied price — no forward-EPS basis at the peer step).

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (263.0); Revenue CAGR ±3pp (129.0); Terminal × ±15% (106.0); Capex intensity ±15% (58.0); WACC ±1pp (39.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 8.5%, terminal multiple 15×, FY+5 revenue $55B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.